ATL1102 Recruiting Phase 2 Trials for Duchenne Muscular Dystrophy (DMD) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT05938023A Study of ATL1102 or Placebo in Participants With Non-ambulatory Duchenne Muscular Dystrophy